Saba Javed/LinkedIn
Aug 10, 2026, 04:33
Saba Javed: Managing VTE in Cancer Patients With Thrombocytopenia
Saba Javed, Assistant Manager, Cystic Fibrosis Clinical Pharmacist and Pediatric Infectious Disease Clinical Pharmacist at The Indus Hospital, shared a post on LinkedIn:
“I am currently reviewing many PICU oncology patients who are being treated with TLS, some of whom are undiagnosed or battling cancer.
It is well-known that oncology patients often have neutropenia and low platelet counts. I am interested in understanding how to manage cases where they develop VTE.
I came across a very informative article that specifies platelet count thresholds for administering or withholding treatment, specifically concerning LMWH (Enoxaparin).
Sharing a quick chart to review.”
Stay updated with Hemostasis Today.
-
Sep 27, 2026, 15:49Rana Al-Hrout: Iron Deficency – Is Ferritin 15ng/mL or Less Still the Cutoff?
-
Sep 27, 2026, 15:49Ayushi Sharma: What I Thought Transfusion Medicine Would Be vs What It Actually Is
-
Sep 27, 2026, 15:48William Wallace: How Much Human Research Is Behind the Supplements We Take?
-
Sep 27, 2026, 15:46Franck Perraudin: Lp(a) Lowering Alone May Not Be Enough
-
Sep 27, 2026, 15:41Ahmed Hamandi: Sharing Real-World HSCT Experience at the Iraqi Society of Haematology Conference
-
Sep 27, 2026, 15:39Co-creating Digital Support With Young Stroke Survivors – European Stroke Organisation
-
Sep 27, 2026, 15:39Eleri Schiavone: Celebrating 80 Years of the Welsh Blood Service
-
Sep 27, 2026, 15:38Jessica Garcia: Standing Where VWD Was First Recognized 100 Years Later
-
Sep 27, 2026, 15:37Heghine Khachatryan: A Meaningful Step Forward for Inherited Blood Disorders in Africa